• LAST PRICE
    11.7100
  • TODAY'S CHANGE (%)
    Trending Up0.2800 (2.4497%)
  • Bid / Lots
    11.3200/ 1
  • Ask / Lots
    16.0000/ 6
  • Open / Previous Close
    11.5800 / 11.4300
  • Day Range
    Low 11.3800
    High 11.7400
  • 52 Week Range
    Low 5.7500
    High 16.3000
  • Volume
    415,267
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 11.43
TimeVolumeIMTX
09:32 ET455111.6
09:34 ET52311.5187
09:36 ET43011.59
09:41 ET17411.59
09:43 ET10011.58
09:48 ET67511.55
09:52 ET20311.51
09:54 ET316811.5499
09:56 ET30011.55
09:57 ET20011.55
09:59 ET386811.6
10:01 ET416611.5
10:03 ET209611.4
10:08 ET324611.525
10:14 ET95011.48
10:15 ET80011.5
10:17 ET20011.5
10:19 ET10011.49
10:21 ET113611.44
10:26 ET20211.4883
10:32 ET110011.41
10:33 ET50011.4
10:39 ET10011.41
10:42 ET50011.44
10:44 ET93011.42
10:46 ET30011.44
10:48 ET10011.45
10:51 ET20011.4499
10:53 ET215711.42
10:55 ET40011.425
10:57 ET10011.52
11:02 ET40011.445
11:04 ET70011.455
11:08 ET60411.46
11:09 ET10011.48
11:11 ET10011.43
11:13 ET35011.4465
11:15 ET20011.45
11:20 ET20011.5
11:22 ET10011.52
11:24 ET20011.511
11:27 ET10011.535
11:29 ET60011.5
11:36 ET20011.54
11:38 ET244611.47
11:40 ET30011.46
11:42 ET60011.5
11:44 ET267511.495
11:45 ET20011.49
11:47 ET10011.5
11:51 ET30011.5
11:58 ET40011.46
12:05 ET40011.5
12:07 ET30011.5
12:09 ET342011.49
12:12 ET15611.5
12:16 ET247611.5
12:20 ET50011.48
12:21 ET40011.5
12:23 ET202211.5
12:25 ET470711.48
12:27 ET40011.5
12:38 ET67511.49
12:41 ET39011.4882
12:48 ET10011.485
12:50 ET83411.485
12:52 ET30011.48
12:54 ET49811.49
12:57 ET70011.45
12:59 ET80011.47
01:06 ET70011.45
01:08 ET50011.44
01:10 ET20011.455
01:12 ET10011.45
01:14 ET80011.4377
01:15 ET111111.424
01:24 ET20011.445
01:26 ET20011.445
01:28 ET27511.455
01:30 ET100011.482
01:33 ET131311.5
01:35 ET110011.47
01:37 ET70011.48
01:39 ET159311.47
01:42 ET20011.46
01:48 ET20011.48
01:50 ET130011.4601
01:51 ET278011.48
01:53 ET646311.48
01:55 ET1320011.5
01:57 ET1154111.5
02:00 ET909111.43
02:02 ET313711.48
02:06 ET983211.48
02:08 ET15151411.525
02:09 ET20011.49
02:11 ET110011.54
02:13 ET220011.64
02:22 ET79811.65
02:24 ET20011.63
02:27 ET42911.625
02:31 ET96211.655
02:33 ET80011.7
02:38 ET150211.66
02:40 ET185611.645
02:44 ET10011.67
02:45 ET326611.63
02:47 ET49011.645
02:49 ET233711.645
02:51 ET30011.67
02:54 ET20011.68
02:56 ET40011.67
03:00 ET140011.68
03:02 ET208811.64
03:05 ET160811.61
03:07 ET40011.6
03:09 ET61411.6
03:12 ET103311.59
03:14 ET10011.6
03:16 ET113511.6
03:18 ET236511.605
03:23 ET170011.6
03:25 ET148111.6
03:27 ET76311.59
03:32 ET328011.57
03:34 ET50011.6
03:36 ET276011.5999
03:38 ET278211.595
03:39 ET40011.595
03:41 ET150011.6
03:43 ET224211.6
03:45 ET354511.6
03:48 ET203811.57
03:50 ET40011.68
03:52 ET931911.66
03:54 ET152611.69
03:56 ET120011.72
03:57 ET381011.725
03:59 ET1424011.71
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMTX
Immatics NV
754.5M
49.4x
---
United StatesYMAB
Y-mAbs Therapeutics Inc
800.5M
-5.9x
---
United StatesBCYC
Bicycle Therapeutics PLC
844.0M
-8.6x
---
United StatesPRTC
PureTech Health PLC
782.2M
-14.1x
---
United StatesNRIX
Nurix Therapeutics Inc
931.9M
-4.8x
---
United StatesKNSA
Kiniksa Pharmaceuticals Ltd
897.6M
-7.6x
---
As of 2022-08-14

Company Information

Immatics NV is a clinical-stage biopharmaceutical company that is based in the Netherlands. The Company is focused on the discovery and development of T-Cell eceptors with the goal of enabling a robust and specific T-Cell response against these targets. The Company develops targeted immunotherapies with an emphasis on treating solid tumors through two distinct therapeutic modalities: Adoptive Cell Therapies (ACT) and antibody-like TCR Bispecifics (TCER). Its wholly owned pipeline comprises of eight therapeutic programs, of which four are in clinical trials, including IMA201 (MAGEA4/8), IMA202 (MAGEA1) and ACTolog IMA 101 (Multi-target pilot trial) for solid cancers and IMA203 (PRAME) for hematological and solid cancers, as well as four are in preclinical development, including IMA204 (COL6A3) and IMA401 (Cancer testis antigen) for solid cancers, and ACTallo IMA301 (Cancer testis antigen) and IMA402 (Cancer testis antigen) for hematological and solid cancers.

Contact Information

Headquarters
Paul Ehrlich-Strasse 15TUEBINGEN, Germany 72076
Phone
---
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$754.5M
Revenue (TTM)
$134.1M
Shares Outstanding
62.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.40
EPS
$0.24
Book Value
$0.39
P/E Ratio
49.4x
Price/Sales (TTM)
5.6
Price/Cash Flow (TTM)
35.0x
Operating Margin
4.63%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.